Literature DB >> 28729152

Reduced-dose ipilimumab with standard-dose pembrolizumab: is less more?

Michael Postow1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28729152     DOI: 10.1016/S1470-2045(17)30518-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients.

Authors:  Michael Constantin Kirchberger; Alvaro Moreira; Michael Erdmann; Gerold Schuler; Lucie Heinzerling
Journal:  Oncotarget       Date:  2018-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.